|
|
Over 4,000 leading researchers and clinicians from around the world convened in Boston for the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The aim of the conference is to help people who are working on relevant HIV/AIDS research – whether in laboratories or in healthcare settings – to share their findings and experiences.
Below is a list of talks and posters by researchers associated with the Botswana–Harvard AIDS Institute Partnership.
Listed by day/time
Monday, February 28
2-4 pm | Hall D
Genetic Determinants of Co-receptor Usage in HIV-1 Subtype C, Poster # 178
Nina Lin, M Sagar, C Becerril, F Giguel, V Novitsky, J Makhema,
R Musonda, M Essex, and D Kuritzkes
 |
| Vlad Novitsky |
2-4 pm | Hall D
Extended Acutes: A Substantial Fraction of Individuals
Maintain High HIV-1 RNA Levels for an Extended Time
during Primary HIV-1 Subtype C Infection, Poster #508
Vladimir Novitsky, T Ndung’u, R Wang, H Bussmann, J Makhema,
V DeGruttola, B Walker, and M Essex
2-4 pm | Hall A
Evaluation of Determine and UniGold Rapid Test Kits for
Serologic Screening of HIV-exposed but Uninfected Infants
under 18 Months of Age in a Modified Testing Algorithm in
Botswana, Poster # 655
Madisa Mine, T Ntsipe, T Nkoane, S Moyo, and T Gaolathe
2-4 pm | Hall B
Neonatal Male Circumcision in Gaborone, Botswana, and
Surrounding Areas: Uptake and Outcomes, Poster # 1005
Rebeca Plank, N Ndubuka, J Mwambona, J Makhema, M Mmalane,
F Hussein, C Lesetedi, D Halperin, R Shapiro, and S Lockman
2-4 pm | Hall B
Longitudinal HIV-1 Exposure Profiles among HIV-discordant
Couples, Poster # 1029
Romel Mackelprang, J Baeten, D Donnell, C Celum, C Farquhar,
G De Bruyn, M Essex, E Nakku-Joloba, J McElrath, J Lingappa, and
Partners in Prevention HSV/HIV Transmission Study Team
Tuesday, March 1
1-2 pm | Room 312 | Themed Discussion
Association between NVP Pharmacokinetics and Development
of Rash and Hepatitis among HIV-infected Sub-Saharan
African Women in ACTG A5208, Poster # 647
Betty Dong, Z Zheng, M Hughes, A Frymoyer, D Verotta, P Lizak,
F Sawe, J Currier, S Lockman, and F Aweeka
1-2pm | Ballroom A | Themed Discussion
Risk Factors for Very Premature and Very Small for
Gestational Age Infants in Botswana, Poster # 745
Natasha Parekh, H Ribaudo, S Souda, J Chen, M Mmalane,
K Powis, S Dryden-Peterson, S Lockman M Essex, and R Shapiro
 |
| Kate Powis |
1-2pm | Ballroom A | Themed Discussion
Protease Inhibitor-based ART Was Associated with Pre-term
Delivery, but Not Adverse Infant Outcomes, in a Randomized
MTCT Prevention Study in Botswana, Poster # 746
Kathleen Powis, D Kitch, A Ogwu, M Hughes, S Lockman,
J Leidner, E van Widenfelt, J Makhema, M Essex, and R Shapiro
2-4 pm | Hall A
ZDV/3TC vs d4T/3TC Outcomes among HIV-1-infected
Adults Receiving First-line Combination ART in Botswana:
Results from a Clinical Trial, Poster # 538
William Wester, M Blevins, H Bussmann, S Moyo, M Farahani,
B Shepherd, J Makhema, M Essex, V deGruttola, and R Marlink
2-4 pm | Hall A
 |
| Aida Asmelash |
Predictors of Suboptimal CD4 Response among Women
Achieving Virologic Suppression in a Randomized ART
Trial, Africa, Poster # 539
A Asmelash, Y Zheng, K Wools-Kaloustian, D Shaffer, F Sawe,
R Salata, E Stringer, J Currier, M Hughes, and Shahin Lockman
2-4 pm | Hall A
Seroprevalence of HPV Vaccine Types 6, 11, 16, and 18 in
HIV+ Women from South Africa, Brazil, and Botswana, Poster # 763
Cynthia Firnhaber, D Evans, R Khalili Friedman, S Williams,
K Mallhagela, C Wester, B Grinsztejn, and S Lockman
2-4 pm | Hall A
Prevalence of HPV Genotypes and Associated Cervical
Squamous Intraepithelial Lesions in HIV+ Women in
Botswana, Poster # 766
Iain MacLeod, B O’Donnell, S Moyo, S Lockman, R Shapiro,
M Kayembe, E van Widenfelt, J Makhema, M Essex, and C Wester
2-4 pm | Hall B
Differential Expression of Inflammatory Cytokine mRNA
Transcripts in Women on an ABC-containing Regimen for
the Prevention of MTCT, Poster # 816
Iain MacLeod, R Shapiro, S Lockman, A Ogwu, C Rowley,
S Moyo, E van Widenfelt, M Mmalane, J Makhema, and M Essex
2-4 pm | Hall B
LPV/r + TDF/FTC Is Associated with Less Favorable
Changes in Lipids Compared to NVP + TDF/FTC in Women
Initiating ART in Sub-Saharan Africa: A5208 (OCTANE), Poster # 818
Douglas Shaffer, Y Bao, A Moses, F Sawe, Y Zheng, M Hughes,
S Lockman, J Currier, and ACTG OCTANE Study Team
Wednesday, March 2
10 am-12 noon | Ballroom A | Themed Discussion
11:00
Infected Partner’s Plasma HIV-1 RNA Level and the
HIV-1 Set Point of Their Heterosexual Seroconverting
Partners, Poster # 134
Jairam Lingappa, K Thomas, J Hughes, J Baeten, K Fife,
G De Bruyn, C Farquhar, S Kapiga, J Makhema, C Celum, and
Partners in Prevention HSV/HIV Transmission Study Team
2-4 pm | Hall A
Association between NVP Pharmacokinetics and Development
of Rash and Hepatitis among HIV-infected Sub-Saharan
African Women in ACTG A5208, Poster # 647
Betty Dong, Z Zheng, M Hughes, A Frymoyer, D Verotta, P Lizak,
F Sawe, J Currier, S Lockman, and F Aweeka
2-4 pm | Hall A
Effectiveness of Maternal HAART vs ZDV to Prevent MTCT
in a Programmatic Setting: Botswana, Poster # 740
Scott Dryden-Peterson, O Jayeoba, H Jibril, K Keapoletswe, J Tlale,
A Asmelash, S Moyo, J Makhema, R Shapiro, and S Lockman
 |
| Scott Dryden-Peterson |
2-4 pm | Hall A
Risk Factors for Very Premature and Very Small for
Gestational Age Infants in Botswana, Poster # 745
Natasha Parekh, H Ribaudo, S Souda, J Chen, M Mmalane,
K Powis, S Dryden-Peterson, S Lockman, M Essex, and R Shapiro
2-4 pm | Hall A
Protease Inhibitor-based ART Was Associated with Pre-term
Delivery, but Not Adverse Infant Outcomes, in a Randomized
MTCT Prevention Study in Botswana, Poster # 746
Kathleen Powis, D Kitch, A Ogwu, M Hughes, S Lockman,
J Leidner, E van Widenfelt, J Makhema, M Essex, and R Shapiro
2-4 pm | Hall A
Increased Maternal and Infant Mortality following Completion
of HAART and Breastfeeding at 6 Months Postpartum in a
Randomized PMTCT Trial: Botswana, the Mma Bana Study, Poster # 747
Roger Shapiro, D Kitch, M Hughes, A Ogwu, S Lockman, S Souda,
K Powis, S Moyo, J Makhema, M Essex, and Mma Bana Study Team
2-4 pm | Hall A
Household Food Insecurity and Survival among HIV-exposed
Uninfected Infants, Botswana, Poster # 748
Scott Dryden-Peterson, O Jayeoba, R Shapiro, H Jibril, T Modise,
A Asmelash, E von Widenfelt, J Makhema, M Essex, and S Lockman
2-4 pm | Hall B
Clinical and Laboratory Risk Factors Associated with
the Development of Moderate to Severe Symptomatic
Hyperlactatemia/Lactic Acidosis among cART-treated
Adults in Botswana, Poster # 852
William Wester, S Eden, H Bussmann, J Makhema, M Farahani,
R D’Aquila, S Moyo, B Shepherd, V deGruttola, and R Marlink
2-4 pm | Hall B
Clinical and Laboratory Risk Factors for the Development of
Pancreatitis among cART-treated Adults: Botswana, Poster # 853
William Wester, S Eden, H Bussmann, J Makhema, S Moyo,
R D’Aquila, B Shepherd, V deGruttola, and R Marlink
|